Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0DD7N
|
|||
Former ID |
DNC000414
|
|||
Drug Name |
CH4474
|
|||
Synonyms |
Methotrexate hydrate; Methotrexate hydrate(1:x); 133073-73-1; L-Amethopterin hydrate; Methotrexate monohydrate; UNII-84DMZ3IHO0; 84DMZ3IHO0; Antifolan hydrate; MTX hydrate; L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- [CAS]; 6745-93-3; Methylaminopterin hydrate; MLS001401431; 4-Amino-10-methylfolic acid hydrate; SMR000449324; Methotrexate trihydrate; Abitrexate(Methotrexate)/; AC1Q5QR4; AC1L4WT9; MLS000758248; L-Amethopterin hydrate, 98%; C20H22N8O5.xH2O; SCHEMBL1230252
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H24N8O6
|
|||
Canonical SMILES |
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O.O
|
|||
InChI |
1S/C20H22N8O5.H2O/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);1H2/t13-;/m0./s1
|
|||
InChIKey |
FPJYMUQSRFJSEW-ZOWNYOTGSA-N
|
|||
CAS Number |
CAS 6745-93-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
10255940, 24278233, 24853414, 24897252, 26719762, 46239541, 46386835, 49681549, 50517770, 57350785, 57653876, 91691137, 92308489, 103828399, 113456622, 117541645, 124658830, 124800364, 134339844, 135122321, 137145255, 152344104, 162178613, 162225145, 164759072, 172080194, 179295900, 224759489, 227460980, 241179861, 242186988, 249828714, 252373058, 252817039
|
|||
SuperDrug ATC ID |
L01BA01
|
|||
SuperDrug CAS ID |
cas=000059052
|
References | Top | |||
---|---|---|---|---|
REF 1 | Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells. Clin Exp Immunol. 2004 Jan;135(1):146-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.